Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
Metabolism: Clinical and Experimental|March 24, 2019
Effects of liraglutide plus phentermine in adults with obesity following 1 year of treatment by liraglutide alone: A randomized placebo-controlled pilot trialJena Shaw Tronieri, Thomas A Wadden, Olivia A Walsh, et al.Obesity Surgery|September 8, 2018
Causal Attributions for Obesity Among Patients Seeking Surgical Versus Behavioral/Pharmacological Weight Loss TreatmentRebecca L Pearl, Thomas A Wadden, Kelly C Allison, et al.Behavioral Medicine (Washington, D.C.)|January 19, 2019
Associations between causal attributions for obesity and long-term weight lossRebecca L Pearl, Thomas A Wadden, Ariana M Chao, et al.Contemporary Clinical Trials|June 11, 2017
Lorcaserin plus lifestyle modification for weight loss maintenance: Rationale and design for a randomized controlled trialJena Shaw Tronieri, Nasreen Alfaris, Ariana M Chao, et al.Obesity Facts|April 16, 2018
Sociocultural and Familial Factors Associated with Weight Bias InternalizationRebecca L Pearl, Thomas A Wadden, Jena Shaw Tronieri, et al.Comprehensive Psychiatry|December 9, 2016
Prevalence and psychosocial correlates of food addiction in persons with obesity seeking weight reductionAriana M Chao, Jena A Shaw, Rebecca L Pearl, et al.International Journal of Obesity (2005)|March 31, 2019
Effects of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trialJena Shaw Tronieri, Thomas A Wadden, Olivia Walsh, et al.Toxics|May 27, 2026
Exploratory Study on Plasticiser Intake During Intermittent Fasting: Effects on Weight, Glycaemic Control and Vitamin D Levels in Type 2 DiabetesEdwina Brennan, Priya Das, Pearl Wasif, et al.Journal of Xenobiotics|February 20, 2026
Evaluation of Plasticiser Levels, Phthalates and Bisphenols in Bahraini Subjects with and Without Type-2 DiabetesEdwina Brennan, Priya Das, Pearl Wasif, et al.Obesity (Silver Spring, Md.)|November 14, 2018
Intensive Behavioral Therapy for Obesity Combined with Liraglutide 3.0 mg: A Randomized Controlled TrialThomas A Wadden, Olivia A Walsh, Robert I Berkowitz, et al.Pageof 5